MVIS US Listed Pharmaceutical 25 Index
A licence agreement is required to use our indices, index data or trademark for any commercial purpose, or for research and analysis, or for the issuance, launch, promotion or marketing of financial products such as exchange-traded products, mutual funds, certificates, derivatives, swaps, bonds or OTC products linked to or based on MVIS indices. Please contact us for information on obtaining a licence.
The MVIS US Listed Pharmaceutical 25 Index Index is currently licensed to underlie the following products:
- VanEck Pharmaceutical ETF